Clinical trial
Pilot Study to Investigate the Feasibility, Reliability and Efficacy of Utilizing OCT to Automate PROSE Fitting
NCT04649177 is registered in ClinicalTrials.gov with Boston Sight as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study to Investigate the Feasibility, Reliability and Efficacy of Utilizing OCT to Automate PROSE Fitting
- Lead sponsor
- Boston Sight
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 15, 2020
- Completion date
- March 23, 2022
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
corneal scar, corneal trauma, dry eye syndromes, ectasia, keratoconjunctivitis sicca, keratoconus, ocular surface disease, pellucid marginal corneal degeneration, sjogren's syndrome